A database of FDA approved therapeutic peptides and proteins
ID1726 | ThPPIDTh1175 | NameDesirudin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandIprivask | CompanyValeant Pharmaceuticals North America LLC | Physical AppearanceNA | Route of AdministartionSubcutaneous | CategoryNA | TargetNA |
ID1727 | ThPPIDTh1175 | NameDesirudin | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandIprivask | CompanyMarathon Pharmaceuticals, LLC | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1745 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandRiastap | CompanyCsl Behring Gmb H | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1746 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandArtiss Frozen | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1747 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandEvicel Fibrin Sealant (human) | CompanyEthicon Inc | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1748 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandRaplixa | CompanyPro Fibrix Bv | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1749 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTachosil | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1750 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTisseel | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1751 | ThPPIDTh1180 | NameFibrinogen Concentrate (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic/Hematological | BrandTisseel Frozen | CompanyBaxter Healthcare Corporation | Physical AppearanceNA | Route of AdministartionNA | CategoryNA | TargetNA |
ID1782 | ThPPIDTh1189 | NameIdarucizumab | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandPraxbind | CompanyBoehringer Ingelheim Pharmaceuticals, Inc. | Physical AppearanceInjection | Route of AdministartionIntravenous | CategoryAnticoagulant | TargetNA |
ID1799 | ThPPIDTh1193 | NameTuroctocog alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandZonovate | CompanyNovo Nordisk Canada Inc | Physical Appearancesterile, non-pyrogenic, white or slightly yellow Powder | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1801 | ThPPIDTh1195 | NameSimoctocog Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandNuwiq | CompanyOctapharma Pharmazeutika Produktionsges M B H | Physical AppearancePowder and solvent for Solution | Route of AdministartionIntravenous infusion | CategoryAntihaemorrhagics: blood coagulation factor VIII | TargetNA |
ID1806 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandFeiba Nf | CompanyBaxter Healthcare Corporation | Physical AppearanceFreeze-dried fraction | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1807 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandCofact | CompanySanquin | Physical AppearanceNA | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1808 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandKcentra | CompanyCsl Behring Ag | Physical AppearanceNanofiltered and Lyophilized non-activated four-factor Prothrombin Complex Concentrate | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1809 | ThPPIDTh1200 | NameProthrombin complex concentrate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandOctaplex | CompanyOctapharma | Physical AppearancePowder and solvent for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1818 | ThPPIDTh1209 | NameMethoxy polyethylene glycol-epoetin beta | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandMircera | CompanyGenentech, Inc. | Physical AppearanceSolution for Injection | Route of AdministartionIntravenous | CategoryNA | Target |
ID1827 | ThPPIDTh1217 | NameAnti-inhibitor coagulant complex | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandFeiba Nf | CompanyNA | Physical Appearance Solid | Route of AdministartionIntravenous | CategoryBlood Coagulation Factors, Antihemophilic Agent | TargetNA |
ID1836 | ThPPIDTh1225 | NameCoagulation factor X human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandCoagadex | CompanyNA | Physical Appearancepowder and solvent used to make a solution | Route of AdministartionIntravenous | CategoryBlood Coagulation Factors | TargetNA |
ID1838 | ThPPIDTh1227 | NameEfmoroctocog alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandELOCTA | CompanyNA | Physical AppearancePowder and solvent for solution for injection | Route of AdministartionIntravenous | CategoryAntihemophilic Factor | TargetNA |
ID1839 | ThPPIDTh1228 | NameFactor IX Complex (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandAlphaNine SD or Mononine | Company | Physical AppearancePowder and solvent for solution for injection | Route of AdministartionIntravenous | CategoryAntihemophilic agent | TargetNA |
ID1846 | ThPPIDTh1234 | NameProtamine sulfate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandProtamine Sulfate Injection, USP | CompanyOmega Laboratories Ltd | Physical Appearanceoff-white amorphous or crystalline powder | Route of AdministartionIntravenous | CategoryHeparin Antagonists, Hematologic Agents | TargetNA |
ID1851 | ThPPIDTh1238 | NameSusoctocog alfa | Peptide SequenceAIRRYYLGAVELSWDYRQSE Full view | Length1448 | Functional ClassificationIb | DiseaseHematological Disorders | BrandObizur | CompanyNA | Physical AppearancePowder and solvent for solution for injection. | Route of AdministartionIntravenous | CategoryBlood coagulation factors, Antihaemorrhagics | Targetvon Willebrand factor |
ID1852 | ThPPIDTh1239 | NameThrombomodulin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandRecomodulin (in Japan only) | CompanyAsahi Kasei Pharma Corp | Physical Appearancelyophilized powder for solution | Route of AdministartionIntravenous | CategoryAnticoagulant agent, Antiplatelet agent | TargetProthrombin, Coagulation factor V |